With life-threatening food allergies on the rise, drug companies ramp up new approaches
date:Sep 28, 2018
.

First is the delivery method: DBV's therapy is administered with a patch that's worn on the child's back. Next is the dose: Every day, patients are administered the equivalent of one one-thousandth of a peanut via the patch, which is called Viaskin. The dose doesn't increase the way Aimmune's does.

It slowly desensitizes the child over time, Kevin Trapp, DBV's chief commercial officer, The child is getting about a peanut over three years.

What kind of protection does that translate into? In
10/18 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/19 12:08